Compare CZWI & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CZWI | EVMN |
|---|---|---|
| Founded | 1938 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.8M | 241.3M |
| IPO Year | 2006 | 2025 |
| Metric | CZWI | EVMN |
|---|---|---|
| Price | $21.36 | $5.22 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 12 |
| Target Price | $22.25 | ★ $22.33 |
| AVG Volume (30 Days) | 32.0K | ★ 841.0K |
| Earning Date | 10-30-2026 | 11-07-2026 |
| Dividend Yield | ★ 1.99% | N/A |
| EPS Growth | 8.96 | ★ 75.23 |
| EPS | ★ 0.50 | N/A |
| Revenue | N/A | ★ $13,000,000.00 |
| Revenue This Year | $6.70 | N/A |
| Revenue Next Year | $10.98 | N/A |
| P/E Ratio | $42.22 | ★ N/A |
| Revenue Growth | N/A | ★ 85.71 |
| 52 Week Low | $15.30 | $5.64 |
| 52 Week High | $24.43 | $33.20 |
| Indicator | CZWI | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 48.28 | 17.76 |
| Support Level | $20.42 | N/A |
| Resistance Level | $21.69 | $13.35 |
| Average True Range (ATR) | 0.45 | 0.46 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 40.76 | 4.29 |
Citizens Community Bancorp Inc is a bank holding company that offers traditional community banking services to businesses, Agricultural operators, and consumers, including one-to-four-family residential mortgages. it also offers a variety of loan products including commercial real estate loans, commercial and industrial (C&I) loans, agricultural real estate loans, agricultural operating loans, residential mortgages, home equity lines-of-credit, and consumer loans and offers deposit products through its branches, including demand deposits, various savings and money-market accounts and certificates of deposit. The company's sources of funds are deposits; amortization, prepayments, and maturities of outstanding loans; other short - term investments; and funds provided from operations.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.